Reference intervals of routine clinical chemistry parameters among apparently healthy young adults in Amhara National Regional State, Ethiopia by Molla Abebe , Mulugeta Melku  , Bamlaku Enawgaw  , Wubet Birhan  , Tekalign Deressa , Betelihem Terefe , Habtamu Wondifraw Baynes
RESEARCH ARTICLE
Reference intervals of routine clinical
chemistry parameters among apparently
healthy young adults in Amhara National
Regional State, Ethiopia
Molla Abebe1*, Mulugeta Melku2, Bamlaku Enawgaw2, Wubet Birhan3, Tekalign Deressa3,
Betelihem Terefe2, Habtamu Wondifraw Baynes1
1 Department of Clinical Chemistry, School of Biomedical and Laboratory Sciences, College of Medicine and
Health Sciences, University of Gondar, Gondar, Ethiopia, 2 Department of Hematology and
Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health
Sciences, University of Gondar, Gondar, Ethiopia, 3 Department of Immunology and Molecular Biology,
School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of
Gondar, Gondar, Ethiopia
* mollish77@gmail.com
Abstract
Background
Clinical laboratory reference intervals (RIs) are essential for clinical diagnosis, treatment
and therapeutic monitoring. Locally established RIs are required to correctly interpret clinical
laboratory results. In Ethiopia, clinical laboratory test results are interpreted based on RIs
derived from a western population.
Methods
A multicenter cross-sectional study was conducted among blood donors in Amhara National
Regional State, Ethiopia from March 2016 to May 2017. A total of 1,175 apparently healthy
study participants were included in the study from four blood banks in the region. All clinical
chemistry parameters were analyzed using Mindray BS-200E full automated clinical chem-
istry analyzer. The 95% RIs were estimated using reference limits at 2.5th percentile for the
lower reference limit and 97.5th percentile for the upper reference limit. Kolmogorov–Smi-
norv and Wilcoxon rank-sum tests were used to check data distribution normality and
whether partitions were needed between variables, respectively.
Results
RIs established include: ALT 5.13–42.88 U/L for males and 4.3–37 U/L for females; AST
12.13–46.88 for males and 10–43.8 U/L for females; ALP 77.2–475.8 U/L for males and 89–
381 U/L for females; amylase 29–309.8 U/L for males and 29–287.9 U/L for females; GGT
7–69.8 U/L for males and 6–39.1 U/L for females; total bilirubin 0.11–1.18 mg/dl for males and
0.08–0.91 mg/dl for females; creatinine 0.48–1.13 mg/dl for males and 0.47–1.09 mg/dl for
females; total cholesterol 78.13–211.75 mg/dl for males and 83.6–202.7 mg/dl for females;
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total protein 5.7–9.7 g/dl for males and 5.6–9.47 for females; triglycerides 36–221.9 mg/dl for
males and 35.3–201.5 mg/dl for females; urea 12–43 mg/dl for males and 10–38.7 mg/dl for
females; and uric acid 2.7–6.9 mg/dl for males and 2.1–5.9 mg/dl for females.
Conclusion
This study has established RIs for routine clinical chemistry parameters. These RIs are
important as they support the interpretation of clinical laboratory results for medical decision
making and other health-related activities.
Introduction
Evidence-based laboratory medicine is an essential part of modern laboratory medicine prac-
tices [1]. It is estimated that clinical laboratory data influence 70% of clinical decisions; often
providing pivotal information for physicians, nurses, public health officers, and other health-
care providers in the prevention, diagnosis, treatment and management of disease [2]. Techno-
logical advancement and economic driving forces have led to major changes in clinical
laboratories globally, primarily represented by an increase in testing productivity and effi-
ciency [3].
In the clinical laboratory, reference interval (RI) is the interval between, and including, two
reference limits. It is the most widely used medical decision-making tool that separates healthy
from diseased individuals. Clinicians compare the values of laboratory reports with the given
RIs to make a decision regarding the health status of a given individual in clinical diagnosis,
treatment and therapeutic monitoring. Therefore, accurate and reliable RI is an integral part
of the process of correct interpretation of clinical laboratory test results for patient care [4–9].
International guidelines recommend that RIs are needed for all tests in the clinical labora-
tory. Clinical laboratories and diagnostic test manufacturers should establish their own RIs for
healthy individuals belonging to a group of homogenous population [10]. However, the major-
ity of clinical laboratories in the world adopt RIs established by manufacturers, rather than
developing their own or verifying the applicability of those RIs to their specific population
[11]. International organizations also recommend that population-specific clinical laboratory
RIs should be established because gender, age, ethnicity, race, diet, geographical location and
other factors could affect the physiological value of biochemical parameters [12].
For many African population, the clinical laboratory RIs have not been established, and
non-locally derived RIs are usually being used in diagnostic laboratories and clinical trials to
screen, diagnose and monitor disease conditions [13]. In Ethiopia, health facilities are depen-
dent on RIs published either in available textbooks or diagnostic kit inserts. Given the dietary
habits, geographical location and ethnic diversity as a source of variability, it is necessary to
establish population-specific RIs for Ethiopian population. Therefore, the aim of this study
was to establish RIs for routine clinical chemistry parameters among healthy adults in Amhara
National Regional State, Ethiopia.
Materials and methods
Study design, period, and setting
A multicenter cross-sectional study was conducted among blood donors in Amhara National
Regional State, Ethiopia from March 2016 to May 2017. The Amhara National Regional State
Reference intervals
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(Fig 1) extends from 9˚ to 13˚ 45’ N and 36˚ to 40˚ 30’E. The altitude ranges from 500–4,620
meters above sea level. Based on the 2007 national census report of Central Statistical Agency
of Ethiopia, the region has a total population of 17,221,976 (8,641,580 men and 8,580,396
women). The region consists 11 zones, 139 weredas (districts) and 3422 kebeles (neighbor-
hoods) (348 urban and 3074 rural). Amhara (91.5%), Agew-Awi (3.5%), Oromo (2.6%) and
Agew Hamyra (1.4%) are the top ranking ethnic groups found in the region. Majority (82.5%)
of people living in the region are Orthodox Christians followed by Muslims (17.2%), Protes-
tants (0.2%), Traditional believers (0.03%) and Catholics (0.02%) [14].
Bahir Dar is the capital city of the region, and it is located 560 Kilometers away from Addis
Ababa, the capital city of Ethiopia. It has an altitude of 1800 meters above sea level with a total
population of 221,991. Debre Markos tow is located 270 Kilometers away from Bahir Dar city.
It has an altitude of 2,446 meters above sea level with a total population of 62,497. Gondar
town is located 175 Kilometers far from Bahir Dar city. It has an altitude of 2,133 meters above
sea level with a total population of 207,044. Dessie town is located 480 Kilometers away from
Bahir Dar city. It has an altitude of 2,470 meters above sea level with a total population of
151,174. The study included those participants who were living in and around the aforemen-
tioned four areas where ethnic, socio-economic, socio-demographic and altitude differences
are not significant among the respective populations [14].
Fig 1. Map of the study area.
https://doi.org/10.1371/journal.pone.0201782.g001
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Reference population
This study included apparently healthy young adults who were selected at each blood donation
centre. Disease history questionnaire, physical examination and infectious disease screening
tests were used to selected eligible study participants. Adults (age: 18–60 years) with normal
body mass index (18–25 kg/m2) were candidates of this study. Whereas, adults with known
disease like, diabetes mellitus, chronic renal insufficiency, hypertension, ischemic heart dis-
ease, anemia, thyroid disease and liver diseases were excluded. Moreover, adults who were tak-
ing medications, chronic alcohol abusers, smokers, pregnant and lactating women, positive for
transfusion transmissible infections (human immune deficiency virus (HIV), hepatitis B virus
(HBV), hepatitis C virus (HCV) and syphilis), and who had a history of jaundice within 3
months and major surgery within 1 year were excluded from the study [10].
Sample size and sampling technique
The Clinical Laboratory Standards Institute/International Federation for Clinical Chemistry
(CLSI/IFCC) recommended non-parametric methods to establish Rls [10]. In order to esti-
mate a non-parametric 95% RI with 95% confidence interval, a minimum of 120 reference
individuals are needed per partition (female and male, in our case). From the six blood banks
in Amhara National Regional State, four were selected systematically considering their geo-
graphical location and population homogeneity. A total of 22 blood donation centres were
included in those four blood banks. Then, the reference individuals were recruited by conve-
nient sampling technique at each blood donation centre. More than 120 adults were included
per partition because some of them were expected to be excluded by infectious disease screen-
ing. A total of 1,290 participants were screened and reviewed at four blood banks of which
1,175 study participants who met the inclusion criteria were selected for this study.
Data collection and laboratory analysis
Data collectors were trained for three days about the objective of the study, study participants’
rights, confidentiality of patient information, procedure of physical examination, procedure of
blood sample collection and measurements, and how to approach and interview participants
before the actual data collection. The study participants were contacted when they came to the
blood donation centres for donation. Study participants who agreed to give written consent
after being informed about the purpose of the study and associated risks were physically exam-
ined and interviewed. Socio-demographic data and blood sample were collected from those
blood donors who fulfilled the criteria set to say apparently healthy.
About 5 ml of blood sample was collected from each study participant using plane tube.
The sample was centrifuged at 2500 rpm (revolution per minute) for 5 minutes to separate
serum. Then, the serum sample was tested for HIV, HBV, HCV and Syphilis at each blood
bank. Sero-negative serum sample was stored at -20˚C until analysis. Finally, the sample was
transported to Amhara Public Health Institute (APHI) for analysis. Mindray BS-200E (Shen-
zhen Mindray Bio-medical electronics co.ltd, China) full automated clinical chemistry analyzer
was used for the measurement of biochemical analytes. HUMAN (HUMAN diagnostics, Ger-
many) reagents including control samples and calibrator were used for all clinical chemistry
parameters determination.
Clinical chemistry parameters were determined by the methods/techniques described as
follows: Alanine aminotransferase and aspartate aminotransferase by kinetic (IFCC without
pyridoxalphosphate activation); alkaline phosphatase (ALP) by optimized standard method of
DGKC (DEA buffer); gamma-glutamyl transferase (GGT) by L-gamma-glutamyl-3-carboxy-
4-nitranilide; amylase by CNP (2-chloro-4-nitrophenol); creatinine by Jaffe (kinetic, without
Reference intervals
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deprotinisation); urea by kinetic urease/GLDH (Glutamate dehydrogenase); uric acid by uri-
case-PAP (4-aminophenazone); total cholesterol by CHOD-PAP (cholesterol peroxidase-
4-aminophenazone); triglycerides by G-PAP (Glycerol -3-phosphate oxidase- 4-aminophena-
zone); total protein by biuret; albumin by bromocresol green; and direct bilirubin and total bil-
irubin by DPD (3,5-dichlorophnyl-diazonium-tetrafloroborate) methods. The viral infectious
diseases (HIV, HBV and HCV), and syphilis were screened by enzyme-linked immunosorbent
assay (ELISA) and rapid plasma reagin (RPR) techniques, respectively.
Laboratory data quality management
All pre-analytical, analytical and post-analytical phases of quality assurance cycle were man-
aged based on standard precautions. Each activity including blood sample collection, transpor-
tation, storage and analysis was based on good laboratory practices (GLP) using standard
operating procedures (SOPs) to ensure data quality. The analysis was done in APHI clinical
chemistry laboratory which is closely supervised by Ethiopian Public Health Institute (EPHI).
The equipment had been calibrated monthly by type-Autocal. In addition, two levels (normal
and pathological) of internal quality control (IQC) samples were run along with the serum
sample. The control sample results were interpreted using Westgard multi-rule algorithm. The
control sample results had to be within acceptable ranges prior serum sample testing. More-
over, the laboratory had been participating in external quality assessment programs like an
onsite evaluation by EPHI and international digital proficiency testing by One World Accu-
racy three times per year.
Data analysis and interpretation
Data were cleared, edited, checked for completeness manually and entered to EPI Info version
3.5.3 (CDC, USA) statistical software, and then transferred to SPSS version 20 (IBM, USA)
software for analysis. Kolmogorov–Sminorv test was used to check data distribution normal-
ity. Wilcoxon rank-sum test was also used to see whether partition was needed between males
and females. RIs were calculated in accordance with CLSI/IFCC guideline using non-paramet-
ric methods [10]. The 95% RIs were estimated using reference limits at 2.5th percentile for the
lower reference limit and 97.5thpercentile for the upper reference limit.
Ethical consideration
The study was conducted after ethical approval was obtained from Research and Ethics Institu-
tional Review Board of the University of Gondar. Informed written consent was also obtained
from each study participant before the actual data collection. Individuals positive for transfu-
sion-transmissible infections and other disease conditions were linked to nearby government
hospitals for further diagnosis and treatment accordingly.
Results
Socio-demographic characteristics
A total of 1,175 apparently healthy young adults were recruited to establish the RI of clinical
chemistry parameters from four blood banks in Amhara National Regional State, Ethiopia.
Out of all study participants, 644 (54.8%) were males. The study participants’ median (IQR)
age was 20 (18–22) year. About 706 (60.1%), 977 (83.1%) and 1,075 (91.5%) of the study partic-
ipants were aged 18–20 years old, students and single, respectively (Table 1).
Reference intervals
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Reference intervals of clinical chemistry parameters
We observed statistically significant differences between males and females in clinical chemis-
try parameters’ RIs. Except total cholesterol, all clinical chemistry parameter values were
higher in males than females (Table 2).
Confidence intervals for reference limits
The 90% CI of lower and upper reference limits of established RIs of clinical chemistry param-
eters are calculated and presented in the table below. Table 3 showed that almost all lower ref-
erence limits have narrow 90% CI than upper reference limits.
Discussion
Nowadays, developing countries like Ethiopia are facing double burden of communicable and
non-communicable diseases [15]. In this regard, clinical laboratory attempts to play a major
role in providing valuable information for prevention, diagnosis and management of life-
threatening diseases [2]. Ethiopian population depends on western derived RIs for disease
diagnosis and management because of lack of locally established RIs. However, a number of
studies showed variations between African and western population derived RIs [16–18]. Thus,
it is required to establish local RIs for adequate medical care and related health issues.
As clearly presented in Table 4, the RIs were different for African and western population;
specially, the upper reference limits of the majority of clinical chemistry parameters were
higher for healthy African population [16, 19–22] than western population [23] (USA and
manufacturer represent the western population). In addition, the western study (USA) [23]
presented a single RI range for both sexes except uric acid. However, the majority of African
based studies [19–22]reported a separate RIs for males and females. These discrepancies are
the cause of misclassifications which may have a negative impact in the diagnosis and manage-
ment of African population. Furthermore, the inconsistency may affect African population in
terms of financial resources and time.
This study showed that there is a significant difference of clinical chemistry parameter val-
ues by sex. All clinical chemistry parameter values were higher among males than females
Table 1. Socio-demographic characteristics of blood donors in Amhara National Regional State blood banks, Ethiopia, 2017 (n = 1,175).
Variables Blood banks Total
Debre Markos Bahir Dar Gondar Dessie
N % N % N % N % N %
Sex Male 176(15.0%) 158(13.4%) 144(12.3%) 166(14.1%) 644(54.8%)
Female 127(10.8%) 135(11.5% 132(11.2%) 137(11.7%) 531(45.2%)
Age 18–20 277(23.6%) 196(16.7%) 137(11.7%) 96(8.2%) 706(60.1%)
21–29 19(1.6%) 92(7.8%) 131(11.1%) 159(13.5%) 401(34.1%)
30–39 5(0.4%) 5(0.4%) 7(0.6%) 31(2.6%) 48(4.1%)
40–61 2(0.2%) 0(0.0%) 1(0.1%) 17(1.4%) 20(1.7%)
Marital status Single 293(24.9%) 288(24.5%) 263(22.4%) 231(19.7%) 1075(91.5%)
Married 10(0.9%) 5(0.4%) 13(1.1%) 72(6.1%) 100(8.5%)
Occupation Student 292(24.9%) 257(21.9) 254(21.6%) 174(14.8%) 977(83.1%)
Employed 11(0.9%) 34(2.9%) 13(1.1%) 67(5.7%) 125(10.6%)
Other 0(0.0%) 2(0.2%) 9(0.8%) 62(5.3%) 73(6.2%)
Total 303(25.8%) 293(24.9%) 276(23.5%) 303(25.8%) 1175(100%)
%: percent, N: number.
https://doi.org/10.1371/journal.pone.0201782.t001
Reference intervals
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Table 2. The RIs of clinical chemistry parameters among blood donors in Amhara National Regional State, Ethiopia, 2017 (N = 1,175; Male = 644, and
Female = 531).
Analytes Unit Sex Mean 95% CI of Mean Median 25th–75th percentile 2.5th–97.5th percentile, RI p-value
ALT/SGPT U/L Combined 15.71 15.22,16.24 14.0 10.0,19.0 5.0–39.0 <0.0001
Male 17.15 16.50,17.88 15.0 12.0,20.0 5.13–42.88
Female 13.97 13.34,14.74 12.0 9.0,16.0 4.3–37.0
AST/SGOT U/L Combined 22.84 22.35,23.36 21.0 17.0,27.0 11.0–46.0 <0.001
Male 24.13 23.46–24.77 23.0 19.0,28.0 12.13–46.88
Female 21.27 20.55,22.04 19.0 16.0,24.0 10.0–43.8
ALP U/L Combined 199.5 194.13,205.24 174.0 141.75,230.0 87.0–451.28 <0.0001
Male 217.55 209.09,225.91 186.0 147.0,269.0 77.20–475.8
Female 177.56 171.28,184.07 162.0 134.0,204.0 89.0–381.0
Amylase U/L Combined 124.84 120.64,128.98 109.0 66.0,172.0 29.0–299.0 <0.0001
Male 131.07 125.45,136.91 121.5 69.0,179.75 29.0–309.8
Female 117.29 111.34,123.32 102.0 61.0,167.0 29.0–287.9
GGT U/L Combined 18.39 17.63,19.15 15.0 11.0,21.0 7.0–58.0 <0.0001
Male 21.08 20.06,22.27 17.0 13.0,24.0 7.0–69.8
Female 15.13 14.34,15.97 13.0 10.0,17.0 6.0–39.1
Bilirubin (direct) mg/dl Combined 0.22 0.21,0.22 0.19 0.13,0.26 0.02–0.61 <0.0001
Male 0.25 0.23,0.26 0.21 0.15,0.3 0.04–0.68
Female 0.18 0.17,0.19 0.17 0.11,0.23 0.01–0.49
Bilirubin (total) mg/dl Combined 0.35 0.34,0.37 0.29 0.21,0.42 0.1–1.1 <0.0001
Male 0.40 0.38,0.42 0.33 0.24,0.46 0.11–1.18
Female 0.30 0.28,0.32 0.25 0.18,0.35 0.08–0.91
Total protein mg/dl Combined 7.59 7.52,7.65 7.5 6.8,8.3 5.7–9.6 <0.0001
Male 7.70 7.61,7.78 7.7 6.9,8.5 5.7–9.7
Female 7.45 7.37,7.54 7.4 6.7,8.2 5.6–9.47
Albumin g/dl Combined 5.0 4.97,5.04 5.0 4.6,5.4 3.7–6.2 <0.0001
Male 5.08 5.03,5.13 5.1 4.6,5.5 3.7–6.2
Female 4.9 4.86,4.95 5.0 4.5,5.3 3.6–6.1
Total cholesterol mg/dl Combined 134.73 132.92,136.56 132.0 113.0,154 80.4–206.6 <0.0001
Male 132.79 130.39,135.31 130.0 111.0,150.0 78.13–211.75
Female 137.08 134.41,139.71 135.0 115.0,159.0 83.6–202.7
Triglycerides mg/dl Combined 96.97 94.28,99.80 86.0 61.0,122.0 36.0–215.6 <0.0001
Male 101.41 97.80,105.00 90.0 63.25,128.75 36.0–221.9
Female 91.59 87.61,95.20 80.0 58.0,115.0 35.3–201.5
Creatinine mg/dl Combined 0.79 0.78,0.80 0.79 0.7,0.88 0.47–1.12 <0.001
Male 0.83 0.82,0.84 0.83 0.75,0.92 0.48–1.13
Female 0.75 0.74,0.76 0.74 0.66,0.82 0.47–1.09
Urea mg/dl Combined 23.35 22.91,23.78 23.0 18.0,28.0 11.0–41.0 <0.0001
Male 24.53 23.95,25.17 24.0 19.0,29.0 12.0–43.0
Female 21.92 21.28,22.51 21.0 17.0,26.0 10.0–38.7
Uric acid mg/dl Combined 4.16 4.10,4.23 4.0 3.3,4.9 2.34–6.60 <0.0001
Male 4.55 4.47,4.63 4.4 3.8,5.2 2.7–6.9
Female 3.68 3.60,3.76 3.5 3.1,4.2 2.1–5.9
P-value: Wilcoxon rank-sum test for male versus female; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; CI: confidence
interval; dl: Decilitre; g: Gram; GGT: Gamma glutamyltransferase; L: litre; mg: Milligram; RI: Reference interval; SGOT: Serum glutamate oxaloacetate transaminase;
SGPT: Serum glutamate pyruvate transaminase; U: Unit.
https://doi.org/10.1371/journal.pone.0201782.t002
Reference intervals
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Table 3. The 90% CI of reference limits of clinical chemistry parameters RIs among blood donors in Amhara National Regional State, Ethiopia, 2017 (N = 1,175;
Male = 644 and Female = 531).
Analytes Unit Sex Range 2.5th–97.5th percentile, RI 90% CI (lower
reference limit)
90% CI (upper
reference limit)
ALT/SGPT U/L Combined 2.0–62.0 5.0–39.0 4.0,5.0 36.0,45.0
Male 3.0–60.0 5.13–42.88 5.0,6.0 36.58,48.57
Female 2.0–62.0 4.3–37.0 4.0,5.0 32.7,42.61
AST/SGOT U/L Combined 4.0–64.0 11.0–46.0 10.0,11.4 42.2,49.0
Male 4.0–63.0 12.13–46.88 12.0,13.0 43.0,51.0
Female 8.0–64.0 10.0–43.8 10.0,11.0 39.0,49.0
ALP U/L Combined 10.0–583.0 87.0–451.28 74.75,93.0 433.0,474.0
Male 10.0–583.0 77.2–475.8 53.0,97.72 453.0,495.48
Female 34.0–575.0 89.0–381.0 80.11,93.8 334.41,403.0
Amylase U/L Combined 10.0–367.0 29.0–299.0 26.4,32.0 286.0,310.0
Male 10.0–367.0 29.0–309.8 25.8,32.0 289.55,317.38
Female 10.0–357.0 29.0–287.9 24.2,33.0 254.0,302.38
GGT U/L Combined 1.0–96.0 7.0–58.0 6.0,7.0 53.0,67.0
Male 1.0–96.0 7.0–69.8 7.0,8.0 57.65,76.0
Female 4.0–89.0 6.0–39.1 6.0,7.0 31.48,49.73
Bilirubin (direct) mg/dl Combined 0.0–0.85 0.02–0.61 0.01,0.04 0.53,0.66
Male 0.0–0.85 0.04–0.68 0.02,0.06 0.6,0.71
Female 0.0–0.85 0.01–0.49 0.0,0.02 0.41,0.59
Bilirubin (total) mg/dl Combined 0.02–1.89 0.1–1.1 0.08,0.10 0.97,1.18
Male 0.02–1.89 0.11–1.18 0.09,0.13 1.1,1.28
Female 0.05–1.39 0.08–0.91 0.73,0.1 0.78,1.04
Total protein mg/dl Combined 4.4–10.9 5.7–9.6 5.6,5.8 9.5,9.7
Male 4.4–10.9 5.7–9.7 5.6,5.9 9.6,9.9
Female 5.1–10.7 5.6–9.47 5.43,5.8 9.21,9.6
Albumin g/dl Combined 3.0–7.3 3.7–6.2 3.6,3.84 6.1,6.2
Male 3.0–7.3 3.7–6.2 3.6,3.9 6.1,6.3
Female 3.1–6.6 3.6–6.1 3.55,3.83 6.0,6.2
Total cholesterol mg/dl Combined 54.0–242.0 80.4–206.60 77.0,83.0 201.0,212.0
Male 55.0–242.0 78.13–211.75 74.0,82.0 202.25,215.66
Female 54.0–235.0 83.6–202.7 78.3,86.0 194.81,210.0
Triglycerides mg/dl Combined 24.0–255.0 36.0–215.6 35.0,37.4 208.2,221.6
Male 24.0–255.0 36.0–221.9 33.66,39.0 213.0,233.84
Female 24.0–250 35.3–201.5 34.48,38.0 190.42,216.07
Creatinine mg/dl Combined 0.16–1.46 0.47–1.12 0.42,0.50 1.08,1.15
Male 0.16–1.46 0.48–1.13 0.38,0.55 1.1,1.15
Female 0.18–1.36 0.47–1.09 0.4,0.51 1.01,1.17
Urea mg/dl Combined 6.0–56.0 11.0–41.0 10.4,12.0 40.0,43.0
Male 8.0–56.0 12.0–43.0 12.0,13.0 40.0,44.0
Female 6.0–50.0 10.0–38.7 10.0,11.0 35.03,41.48
Uric acid mg/dl Combined 1.7–10.0 2.34–6.60 2.24,2.4 6.5,6.8
Male 1.8–10.0 2.7–6.9 2.5,2.8 6.66,7.0
Female 1.7–7.3 2.1–5.9 2.0,2.24 5.5,6.39
ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; CI: confidence interval; dl: Decilitre; g: Gram; GGT: Gamma
glutamyltransferase; L: litre; mg: Milligram; RI: Reference interval; SGOT: Serum glutamate oxaloacetate transaminase; SGPT: Serum glutamate pyruvate transaminase;
U: Unit.
https://doi.org/10.1371/journal.pone.0201782.t003
Reference intervals
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Table 4. Comparison of clinical chemistry parameter RIs of this study against manufacturer ranges and other similar studies.
Analytes Sex Current
study
Manufacturer Northwest Ethiopia
[16]
Southwest Ethiopia
[19]
Uganda
[20]
Tanzania
[21]
Ghana
[22]
USA
[23]
ALT/SGPT (U/L) Combined 5.0–39.0 NA 6.0–43.0 11.0–54.0 6.6–42.8 7.7–48.3 7–51 0–35
Male 5.13–42.88 0–42 6.0–44.6 11.2–56.0 7.2–43.3 9.1–55. 8–54 NA
Female 4.3–37.0 0–32 3.0–30.0 10.1–54.0 5.3–39.9 6.7–44.9 6–51 NA
AST/SGOT (U/L) Combined 11.0–46.0 NA 9.0–38.0 12.0–59.0 12.3–34.8 14.3–48.1 14–51 0–35
Male 12.13–46.88 0–37 10.5–39.0 13.0–59.5 13.2–35.9 15.2–53.4 17–60 NA
Female 10.0–43.8 0–31 6.0–32.1 12.0–59.9 11.4–28.8 13.5–35.2 13–48 NA
ALP(U/L) Combined 87.0–451.28 NA 52.4–237.0 63.0–376.0 44–151 45.6–158.4 85–241 30–120
Male 77.2–475.8 80–306 55.3–237.2 55.8–362.9 42–159 45.4–170.4 101–353 NA
Female 89.0–381.0 64–306 49.0–236.0 70.4–384.4 47–160 45.3–155.0 82–293 NA
Amylase (U/L) Combined 29.0–299.0 0–220 48.0–188.8 NA 45.6–173.6 42.8–164.4 32–139 60–180
Male 29.0–309.8 NA 45.3–190.0 NA 46–175 49.6–180.1 34–137 NA
Female 29.0–287.9 NA 48.0–187.9 NA 44–177 41.8–160.4 30–139 NA
GGT(U/L) Combined 7.0–58.0 9–64 NA NA 8.5–68.5 8.1–107.8 7–61 1–94
Male 7.0–69.8 NA NA NA 8.7–70.7 9.3–120.8 9–71 NA
Female 6.0–39.1 NA NA NA 8.0–41.3 7.3–51.8 6–53 NA
Bilirubin (direct)
(mg/dl)
Combined 0.02–0.61 0–0.2 0.01–0.80 NA 0.02–0.4 0.04–0.48 0.05–0.23 0.1–0.3
Male 0.04–0.68 NA 0.02–0.84 NA 0.1–0.5 0.05–0.49 0.05–0.24 NA
Female 0.01–0.49 NA 0.01–0.71 NA 0.0–0.4 0.04–0.34 0.04–0.22 NA
Bilirubin (total) (mg/
dl)
Combined 0.1–1.1 0.1–1.2 0.26–2.20 NA 0.4–2.5 0.30–2.40 0.17–1.51 0.3–1.0
Male 0.11–1.18 NA 0.27–2.20 NA 0.4–2.6 0.35–2.46 0.22–1.87 NA
Female 0.08–0.91 NA 0.21–2.20 NA 0.3–1.9 0.26–1.83 0.16–1.56 NA
Total protein (g/dl) Combined 5.7–9.6 6.6–8.7 5.3–8.6 4.4–11.6 6.6–8.9 6.6–8.5 5.1–8.7 5.5–8.0
Male 5.7–9.7 NA 5.3–8.7 4.0–11.4 6.5–8.9 6.7–8.5 4.7–8.6 NA
Female 5.6–9.47 NA 5.3–8.6 4.6–11.7 6.8–9.0 6.6–8.6 5.5–8.7 NA
Albumin (g/dl) Combined 3.7–6.2 3.8–5.1 NA NA 3.8–5.3 3.6–5.0 3.3–5.0 3.5–5.5
Male 3.7–6.2 NA NA NA 3.9–5.4 3.7–5.1 3.3–5.0 NA
Female 3.6–6.1 NA NA NA 3.7–5.2 3.6–4.9 3.4–5.0 NA
Total cholesterol (mg/
dl)
Combined 80.4–206.60 0–190 NA 55.0–276.0 91–233 95.5–213.8 77.3–
208.1
<200
Male 78.13–211.75 NA NA 52.1–252.2 90–235 89.7–219.3 69.6–
193.3
NA
Female 83.6–202.7 NA NA 58.0–286.4 100–230 109–212.7 81.2–
216.6
NA
Triglycerides (mg/dl) Combined 36.0–215.6 0–150 NA 41.0–264.0 39–281 34.5–255.1 35.4–
194.9
<160
Male 36.0–221.9 NA NA 41.3–275.8 39–299 34.5–266.6 35.4–
194.9
NA
Female 35.3–201.5 NA NA 41.0–261.2 34–206 33.7–193.1 35.4–186 NA
Creatinine (mg/dl) Combined 0.47–1.12 NA 0.23–1.22 0.32–1.32 0.5–1.2 0.48–1.02 0.55–1.33 <1.5
Male 0.48–1.13 0.6–1.1 0.20–1.29 0.3–1.4 0.6–1.2 0.54–1.09 0.63–1.35 NA
Female 0.47–1.09 0.5–0.9 0.25–1.08 0.3–1.3 0.5–0.9 0.45–0.92 0.53–1.24 NA
Urea (mg/dl) Combined 11.0–41.0 10–50 NA 4.6–35.0 9.9–33.2 9.1–29.5 5.4–34.2 21.4–
42.9
Male 12.0–43.0 NA NA 4.6–34.5 10.1–33.9 9.3–29.8 5.4–37.2 NA
Female 10.0–38.7 NA NA 4.5–35.8 9.4–30.2 8.8–27.4 5.4–32.4 NA
(Continued)
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except for total cholesterol; females had higher total cholesterol value than males. Our study
findings are consistent with previous reports of other African countries where there were sig-
nificant differences for the majority of clinical chemistry parameter values by sex although the
higher and lower values were different across studies for both sexes [16, 18, 24, 25].
There is observable clinical chemistry parameter RIs variation between the current study
and studies conducted in northwest Ethiopia [16] and southwest Ethiopia [19] (Tables 3 and
4). Except for ALT, there are RIs differences between current study and northwest Ethiopian
study. Similarly, the RIs of all clinical chemistry parameters established by southwest Ethiopian
study don’t match with our study. These inconsistencies may be due to demographic differ-
ences; in the current study, the majority of the study participants were young adults, but the
northwest and southwest Ethiopian studies included participants with wider age range (15 to
>65 years). Geographic (around 800 Kilometers gap between the current and southwest Ethio-
pian study areas) and ethnic differences may be accountable for the observed variations. In
addition, variablity of analysis methods, equipments and reagents being used may affect the
value of clinical chemistry parameters in this different studies [10].
Clinical chemistry parameter RIs are variable among studies conducted in different countries
including our study (Tables 3 and 4, [17, 26]). The ALP, amylase, direct bilirubin, albumin and
total protein upper reference limits of the current study are higher than studies done in Uganda
[20], Tanzania [21], Ghana [22] and USA [23]. On the contrary, the total cholesterol, triglycerides
and uric acid upper reference limits of the current study are lower than studies in Uganda, Tanza-
nia and India [20, 21, 27]. In addition, GGT, total bilirubin and total cholesterol upper reference
limits of this study are in line with those from Ghana [22]. Ethnic, genetic, demographic, nutri-
tional, cultural, life style, disease distribution, and seasonal differences are important factors which
affect the values of clinical laboratory RIs among apparently healthy individuals [27–30]. Further-
more, a number of studies and international guidelines recommended that local clinical labora-
tory RIs should be established for each homogenous population [10, 31, 32].
This study was limited to young adult blood donors and unable to include children, adoles-
cents and older individuals. Thus, we were not able to confirm whether or not partition
among different age groups was needed for clinical chemistry parameter RIs. Dietary pattern
of study participants was not assessed because it was difficult to standardize it based on inter-
national guidelines. In addition, the resource has limited us to establish the RIs only for rou-
tinely requested clinical chemistry parameters in Ethiopian setting.
Conclusion
The established RIs of clinical chemistry parameters are potentially useful in the diagnosis,
management and monitoring of disease progression in the study setting. There are significant
RIs variations between the current and other Ethiopian studies. Therefore, further local and
Table 4. (Continued)
Analytes Sex Current
study
Manufacturer Northwest Ethiopia
[16]
Southwest Ethiopia
[19]
Uganda
[20]
Tanzania
[21]
Ghana
[22]
USA
[23]
Uric acid (mg/dl) Combined 2.34–6.60 NA NA 2.0–7.4 3.3–7.8 2.8–7.5 1.5–6.7 NA
Male 2.7–6.9 3.4–7.0 NA 2.5–7.9 3.5–8.0 3.3–7.7 2.1–7.0 2.5–8.0
Female 2.1–5.9 2.4–5.7 NA 2.0–7.2 3.0–6.8 2.5–6.1 1.4–6.4 1.5–6.0
ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; CI: confidence interval; dl: Decilitre; g: Gram; GGT: Gamma
glutamyltransferase; L: litre; mg: Milligram; NA: Not available; SGOT: Serum glutamate oxaloacetate transaminase; SGPT: Serum glutamate pyruvate transaminase;
USA: United States of America; U: Unit.
https://doi.org/10.1371/journal.pone.0201782.t004
Reference intervals
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nationwide studies, including all age and ethnic groups, are recommended to establish local
and national RIs for clinical chemistry parameters.
Supporting information
S1 File. “Data set used for analysis” includes data on reference intervals of clinical chemis-
try parameters.
(XLSX)
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